Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario La Fe (13)

2022

  1. Clinical characteristics, health care resource utilization and direct medical costs of Rotavirus hospitalizations in Spain (2013–2018)

    Human Vaccines and Immunotherapeutics, Vol. 18, Núm. 5

  2. Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort

    Clinical Rheumatology, Vol. 41, Núm. 12, pp. 3759-3768

2021

  1. Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) study group

    AIDS, Vol. 35, Núm. 12, pp. 1973-1985

  2. Mortality in Perinatally HIV-infected Adolescents after Transition to Adult Care in Spain

    Pediatric Infectious Disease Journal, Vol. 40, Núm. 4, pp. 347-350

  3. Rotavirus gastroenteritis hospitalizations in provinces with different vaccination coverage rates in Spain, 2013–2018

    BMC Infectious Diseases, Vol. 21, Núm. 1

2020

  1. Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Sociodemographic changes and trends in the rates of new perinatal HIV diagnoses and transmission in Spain from 1997 to 2015

    PLoS ONE, Vol. 14, Núm. 10

2018

  1. Current aspects in sepsis approach. Turning things around

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 4, pp. 298-315

2017

  1. Performance of a quantitative pcrbased assay and beta-D-glucan detection for diagnosis of invasive candidiasis in very-low-birth-weight preterm neonatal patients (candineo study)

    Journal of Clinical Microbiology, Vol. 55, Núm. 9, pp. 2752-2764

2010

  1. Long-term efficacy and safety of fosamprenavir in human immunodeficiency virus-infected pediatric patients

    Pediatric Infectious Disease Journal, Vol. 29, Núm. 6, pp. 563-566

2006

  1. Antiretroviral activity and safety of lopinavir/ritonavir in protease inhibitor-experienced HIV-infected children with severe-moderate immunodeficiency [4]

    Journal of Antimicrobial Chemotherapy

2005

  1. Safety and antiviral response at 12 months of lopinavir/ritonavir therapy in human immunodeficiency virus-1-infected children experienced with three classes of antiretrovirals

    Pediatric Infectious Disease Journal, Vol. 24, Núm. 10, pp. 867-873

2001

  1. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus: European Paediatric Hepatitis C Virus Network

    British Journal of Obstetrics and Gynaecology, Vol. 108, Núm. 4, pp. 371-377